REYNOLDS MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
REYNOLDS MEMORIAL HOSPITAL is a 94-bed suburban community hospital in MARSHALL, WV with $123.6M in net patient revenue and a 3.8% operating margin. The hospital serves a payer mix of 24.9% Medicare, 4.5% Medicaid, and 70.7% commercial.
Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.8% to 11.1% (+736bps).
| Net Revenue HCRIS | $123.6M |
| Current EBITDA COMPUTED | $4.7M |
| Operating Margin COMPUTED | 3.8% |
| Occupancy HCRIS | 43.9% |
| Revenue / Bed COMPUTED | $1.3M |
| Net-to-Gross HCRIS | 34.9% |
| Distress Probability ML | 49.9% |
2. Market Context & Competitive Position
WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 3.8% places it above the state median. Among 20 size-comparable peers (47-188 beds), the median margin is 1.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (47-188), prioritizing same-state peers. 20 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| REYNOLDS MEMORIAL HOSPITAL (Target) | WV | 94 | $123.6M | 3.8% |
| CITY HOSPITAL INC. | WV | 163 | $304.2M | -2.8% |
| PRINCETON COMMUNITY HOSPITAL | WV | 115 | $290.2M | 12.8% |
| THOMAS MEMORIAL HOSPITAL | WV | 176 | $209.0M | 26.7% |
| WEIRTON MEDICAL CENTER | WV | 127 | $182.4M | 9.4% |
| MONONGALIA GENERAL HOSPITAL | WV | 160 | $155.1M | -5.3% |
| BECKLEY ARH | WV | 72 | $109.2M | -37.8% |
| LOGAN REGIONAL MEDICAL CENTER | WV | 132 | $104.0M | 3.4% |
| DAVIS MEMORIAL HOSPITAL | WV | 90 | $100.9M | -20.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $79K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $4.7M |
| + RCM Uplift | +$9.1M |
| Pro Forma EBITDA | $13.8M |
| Current Margin | 3.8% |
| Pro Forma Margin | 11.1% |
| WC Released (1x) | $4.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $7.2M | $121.8M | 16.95x | 76.1% |
| Base (11x exit) | 10.0x | 11.0x | $7.2M | $136.3M | 18.97x | 80.1% |
| Bull Case | 9.0x | 11.0x | $6.5M | $168.7M | 26.08x | 92.0% |
| Bull (12x exit) | 9.0x | 12.0x | $6.5M | $185.9M | 28.74x | 95.8% |
| Bear Case | 11.0x | 10.0x | $7.9M | $74.0M | 9.36x | 56.4% |
| Bear (11x exit) | 11.0x | 11.0x | $7.9M | $83.9M | 10.62x | 60.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 20 hospitals with 47-188 beds
- Same-state prioritization (n=21)
- Comp margins: P25=-14.0% / P50=1.3% / P75=12.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.